A case of Anti-MDA5-Positive dermatomyositis after inactivated COVID-19 vaccine.
作者信息
Yang Lili, Ye Tinglu, Liu Huanyu, Huang Cong, Tian Weiwei, Cai Yueming
机构信息
Department of Dermatology, Institute of Dermatology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
Department of Dermatology, Central Laboratory, Huzhou Central Hospital, Huzhou, China.
出版信息
J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e127-e129. doi: 10.1111/jdv.18653. Epub 2022 Oct 31.
Abstract
摘要
相似文献
1
A case of Anti-MDA5-Positive dermatomyositis after inactivated COVID-19 vaccine.1例新型冠状病毒灭活疫苗接种后抗MDA5阳性皮肌炎病例。
J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e127-e129. doi: 10.1111/jdv.18653. Epub 2022 Oct 31.
2
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review.COVID-19 疫苗接种后抗 MDA5 皮肌炎：基于病例的综述。
Rheumatol Int. 2022 Sep;42(9):1629-1641. doi: 10.1007/s00296-022-05149-6. Epub 2022 Jun 4.
3
A case of anti-MDA5 antibody-positive dermatomyositis with severe necrosis on limbs after COVID-19 vaccination.
J Dermatol. 2023 Dec;50(12):e402-e403. doi: 10.1111/1346-8138.16906. Epub 2023 Jul 24.
4
Inverse Gottron's Sign in A Patient With Anti-MDA5 Associated Dermatomyositis With Rapidly Progressive Interstitial Lung Disease.一名患有抗MDA5相关皮肌炎并伴有快速进展性间质性肺病患者的反向Gottron征
Am J Med Sci. 2021 Oct;362(4):e35. doi: 10.1016/j.amjms.2021.02.008. Epub 2021 Feb 12.
5
Cutaneous Ulcerations in Anti-MDA5 Dermatomyositis.抗MDA5皮肌炎中的皮肤溃疡
N Engl J Med. 2019 Aug 1;381(5):465. doi: 10.1056/NEJMicm1816147.
6
The clinical spectrum of dermatomyositis and the new autoantibodies - with regard to two clinical cases with distinct associations.皮肌炎的临床特征和新的自身抗体——基于两例具有明显关联的临床病例。
Australas J Dermatol. 2020 May;61(2):e241-e243. doi: 10.1111/ajd.13232. Epub 2019 Dec 27.
7
Anti-MDA5-Positive Dermatomyositis: A Description of the Cutaneous and Systemic Manifestations in 2 Cases.抗MDA5阳性皮肌炎：2例患者的皮肤及全身表现描述
Actas Dermosifiliogr (Engl Ed). 2018 Mar;109(2):188-190. doi: 10.1016/j.ad.2017.05.017. Epub 2017 Nov 20.
8
Pharyngeal ulceration and perforation: a rare manifestation in anti-MDA5 dermatomyositis.
Rheumatology (Oxford). 2021 Apr 6;60(4):e132-e133. doi: 10.1093/rheumatology/keaa730.
9
Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease disguising as anti-synthetase syndrome.抗MDA5抗体阳性皮肌炎合并快速进展性间质性肺病，伪装成抗合成酶综合征。
Rheumatology (Oxford). 2021 Mar 2;60(3):e104-e106. doi: 10.1093/rheumatology/keaa507.
10
Panniculitis as the initial manifestation of dermatomyositis with anti-MDA5 antibody.脂膜炎作为抗MDA5抗体阳性皮肌炎的初始表现
Clin Exp Dermatol. 2017 Jul;42(5):551-553. doi: 10.1111/ced.13128. Epub 2017 May 22.
引用本文的文献
1
MDA5 Is a Major Determinant of Developing Symptoms in Critically Ill COVID-19 Patients.黑色素瘤分化相关基因5（MDA5）是危重症COVID-19患者出现症状的主要决定因素。
Clin Rev Allergy Immunol. 2024 Dec;67(1-3):58-72. doi: 10.1007/s12016-024-09008-z. Epub 2024 Oct 26.
2
Multivariate logistic regression analysis of poor prognosis of dermatomyositis and clinical value of ferritin/Kl-6 in predicting prognosis.多变量逻辑回归分析皮肌炎不良预后及铁蛋白/KL-6 预测预后的临床价值。
Skin Res Technol. 2024 May;30(5):e13701. doi: 10.1111/srt.13701.
3
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress.抗 MDA5 抗体阳性皮肌炎：发病机制与临床进展。
Nat Rev Rheumatol. 2024 Jan;20(1):48-62. doi: 10.1038/s41584-023-01054-9. Epub 2023 Dec 6.
本文引用的文献
1
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review.COVID-19 疫苗接种后抗 MDA5 皮肌炎：基于病例的综述。
Rheumatol Int. 2022 Sep;42(9):1629-1641. doi: 10.1007/s00296-022-05149-6. Epub 2022 Jun 4.
2
Immunogenicity of COVID-19 vaccines in patients with diverse health conditions: A comprehensive systematic review.不同健康状况患者中新冠病毒疫苗的免疫原性：一项全面的系统评价
J Med Virol. 2022 Sep;94(9):4144-4155. doi: 10.1002/jmv.27828. Epub 2022 May 27.
3
COVID-19 vaccine-associated dermatomyositis.新型冠状病毒肺炎疫苗相关的皮肌炎
JAAD Case Rep. 2022 May;23:58-60. doi: 10.1016/j.jdcr.2022.02.023. Epub 2022 Mar 2.
4
Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination.接种 BNT162b2 mRNA COVID-19 疫苗后出现皮肌炎。
J Korean Med Sci. 2022 Feb 7;37(5):e32. doi: 10.3346/jkms.2022.37.e32.
5
Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study.抗 MDA5 抗体的存在及其对 COVID-19 患者临床评估的价值：一项回顾性队列研究。
Front Immunol. 2021 Dec 20;12:791348. doi: 10.3389/fimmu.2021.791348. eCollection 2021.
6
Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease.抗 MDA5 阳性伴间质性肺病的无肌病性皮肌炎中抗 Ro52 抗体的预后价值。
Rheumatology (Oxford). 2021 Jul 1;60(7):3343-3351. doi: 10.1093/rheumatology/keaa786.
7
Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.自身免疫性皮肌炎患者体内针对与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）具有高度序列同一性的免疫原性表位的抗体。
Ann Rheum Dis. 2020 Oct;79(10):1383-1386. doi: 10.1136/annrheumdis-2020-217522. Epub 2020 May 22.
8
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.2017年欧洲抗风湿病联盟/美国风湿病学会成人及青少年特发性炎性肌病及其主要亚组的分类标准。
Ann Rheum Dis. 2017 Dec;76(12):1955-1964. doi: 10.1136/annrheumdis-2017-211468. Epub 2017 Oct 27.
Zotero 插件